Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Taiwan
Clinical trial register · Taiwan

Clinical Trials in Taiwan

Every study on the ClinicalTrials.gov registry that lists a site in Taiwan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2861 matching records held by the registry are in this view. Synced 15 Nov 2026, 03:18 UTC
2861
Studies in scope
all four open statuses
1565
Recruiting now
open to new participants
340
Lead sponsors
across recruiting studies
Top sites
Taipei 34 Tainan 19 Taichung 17 Kaohsiung City 17 Taoyuan 12

Trials in this register

35 of 2861 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Taiwan
Start
Recruiting
Amgen
Phase 2
30
Taipei
2026-05-07
Recruiting
AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors
NCT07403721Metastatic or Locally Advanced Solid Tumors With Microsatellite Instability-high (MSI-H) or Mismatched Repair Deficiency (dMMR)
Amgen
Phase 1
464
Taipei
2026-04-08
Recruiting
Amgen
Phase 2
14
Taichung
2026-01-02
Recruiting
Amgen
Phase 3
750
Kaohsiung City, Taichung, Tainan, Taipei
2025-11-28
Active, closed
Amgen
Phase 3
350
Tainan, Taipei
2025-08-18
Active, closed
Amgen
Phase 3
12,800
Kaohsiung City, Taichung, Taipei, Taoyuan
2025-07-25
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
Amgen
Phase 3
5,056
Kaohsiung City, Taichung, Tainan, Taipei
2025-06-25
Recruiting
Amgen
Phase 3
844
Kaohsiung City, Taichung, Taipei, Taoyuan
2025-02-25
Active, closed
Amgen
Phase 2
61
Taichung, Tainan, Taipei
2024-12-26
Active, closed
Amgen
Phase 3
707
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2024-12-09
Active, closed
Amgen
Phase 2
409
Kaohsiung City, Tainan, Taipei
2024-11-07
Active, closed
Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)
NCT06430866Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC)
Amgen
Phase 3
163
Taipei, Kaohsiung City, Kaohsiung County, Taichung, Tainan
2024-09-12
Active, closed
Amgen
Phase 3
315
Neihu, Taipei, Chiayi City, Douliu, Kaohsiung City, Kaohsiung County, New Taipei City, Taichung
2024-09-09
Active, closed
Amgen
Phase 3
563
Kaohsiung City, Tainan, Taipei
2024-06-05
Active, closed
Amgen
Phase 1/2
94
Taipei
2024-05-30
Active, closed
Amgen
Phase 3
434
Kaohsiung City, Taichung, Taipei, Taoyuan City
2024-04-08
Active, closed
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
NCT06117774Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer
Amgen
Phase 3
404
Kaohsiung City, Taipei
2024-02-20
Active, closed
Amgen
Phase 3
633
Taichung, New Taipei City, Changhua, Taipei
2023-11-02
Active, closed
Amgen
Phase 4
36
Taipei
2023-08-17
Active, closed
Amgen
Phase 3
509
Kaohsiung City, Taichung, Tainan, Taipei
2023-05-31
Active, closed
Amgen
Phase 3
7,297
Hualien City, Kaohsiung City, New Taipei City, Taichung, Tainan, Taipei, Taoyuan
2022-12-14
Active, closed
Amgen
Phase 1/2
329
Tainan, Taipei, Taoyuan
2022-02-01
Active, closed
A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC)
NCT05060016Relapsed/Refractory Small Cell Lung Cancer
Amgen
Phase 2
222
Kaohsiung City, Taipei
2021-12-01
Active, closed
Amgen
Phase 3
303
Taichung, Tainan, Taipei, Taoyuan
2021-11-02
Active, closed
Myasthenia Gravis Inebilizumab Trial
NCT04524273Myasthenia Gravis
Amgen
Phase 3
238
Kaohsiung City, New Taipei City, Tainan, Taipei, Taoyuan City
2020-10-15
Recruiting
Amgen
Phase 1
505
Taipei, Taoyuan
2020-03-04
Active, closed
Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
NCT04185883Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C Mutation
Amgen
Phase 1
610
Tainan, Taipei, Taoyuan
2019-12-17
Recruiting
Amgen
Phase 3
56
Kaohsiung City, Tainan, Taipei, Taoyuan
2019-04-29
Active, closed
Amgen
Phase 1
269
Kaohsiung City, Taipei, Taoyuan
2017-12-26
Rows per page Showing 1–35 of 35
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Taiwanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 16 November 2026. https://priyalifescience.com/clinical-trials-taiwan

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Taiwan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,861 studies in total at the last sync on 15 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 35 of those studies that match the filters currently applied.

How many clinical trials are recruiting in Taiwan?

10 of the 35 studies on this page are recruiting new participants as of the 15 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 25 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase, 35 studies
PhaseStudiesRecruitingShare
Phase 320657.1%
Phase 17220%
Phase 25214.3%
Phase 1/2205.7%
Phase 4102.9%

Most active sponsors

Lead sponsors with the most studies
Lead sponsorStudiesRecruiting
Amgen3510

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Thyroid Eye Disease (3) Advanced Solid Tumors (2) Obesity (2) Atherosclerotic Cardiovascular Disease (2) Metastatic Castration-resistant Prostate Cancer (2) Prostate Cancer (1) Thoracic Tumors (1) Non-small Cell Lung Cancer (1) Small-cell Lung Cancer (1) Extensive Stage Small-cell Lung Cancer (1) Non-Small Cell Lung Cancer (NSCLC) (1) Type 2 Diabetes Mellitus (T2DM) (1) Relapsed/Refractory Small Cell Lung Cancer (1) Myasthenia Gravis (1) Sjögren's Syndrome (SS) (1)
→

Browse trials by site location

Taipei (34) Tainan (19) Taichung (17) Kaohsiung City (17) Taoyuan (12) New Taipei City (4) Taoyuan City (2) Hualien City (1) Changhua County (1) Chiayi City (1) Douliu (1) Changhua (1)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.